Cargando…
Rational Design of SARS-CoV-2 Spike Glycoproteins To Increase Immunogenicity By T Cell Epitope Engineering
The current COVID-19 pandemic caused by SARS-CoV-2 has resulted in millions of confirmed cases and thousands of deaths globally. Extensive efforts and progress have been made to develop effective and safe vaccines against COVID-19. A primary target of these vaccines is the SARS-CoV-2 spike (S) prote...
Autores principales: | Ong, Edison, Huang, Xiaoqiang, Pearce, Robin, Zhang, Yang, He, Yongqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430581/ https://www.ncbi.nlm.nih.gov/pubmed/32817949 http://dx.doi.org/10.1101/2020.08.14.251496 |
Ejemplares similares
-
Computational design of SARS-CoV-2 spike glycoproteins to increase immunogenicity by T cell epitope engineering
por: Ong, Edison, et al.
Publicado: (2020) -
A rational design of a multi-epitope vaccine against SARS-CoV-2 which accounts for the glycan shield of the spike glycoprotein
por: Martin, William R., et al.
Publicado: (2020) -
Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting
por: Hauser, Blake M., et al.
Publicado: (2022) -
The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens
por: Duan, Liangwei, et al.
Publicado: (2020) -
Identification of New Features from Known Bacterial Protective Vaccine Antigens Enhances Rational Vaccine Design
por: Ong, Edison, et al.
Publicado: (2017)